Back to Top
Antibody Drug Conjugate
-
-
-
Depatuxizumab-Mafodotin Biosimilar - Research Grade$700.00 - $3,024.00
-
Telisotuzumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
-
-
-
-
-
Glembatumumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
Iladatuzumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
Who Bought This Also Bought
